Literature DB >> 26922909

Purinergic regulation of the immune system.

Caglar Cekic1, Joel Linden2.   

Abstract

Cellular stress or apoptosis triggers the release of ATP, ADP and other nucleotides into the extracellular space. Extracellular nucleotides function as autocrine and paracrine signalling molecules by activating cell-surface P2 purinergic receptors that elicit pro-inflammatory immune responses. Over time, extracellular nucleotides are metabolized to adenosine, leading to reduced P2 signalling and increased signalling through anti-inflammatory adenosine (P1 purinergic) receptors. Here, we review how local purinergic signalling changes over time during tissue responses to injury or disease, and we discuss the potential of targeting purinergic signalling pathways for the immunotherapeutic treatment of ischaemia, organ transplantation, autoimmunity or cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26922909     DOI: 10.1038/nri.2016.4

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  207 in total

1.  Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells.

Authors:  Aleta Pupovac; Nicholas J Geraghty; Debbie Watson; Ronald Sluyter
Journal:  Immunol Cell Biol       Date:  2014-08-26       Impact factor: 5.126

2.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

3.  Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.

Authors:  Yunyun Su; Edwin K Jackson; Elieser Gorelik
Journal:  Cancer Immunol Immunother       Date:  2010-10-20       Impact factor: 6.968

4.  Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.

Authors:  Jared J Butler; Jamie S Mader; Carrie L Watson; Hong Zhang; Jonathan Blay; David W Hoskin
Journal:  J Cell Biochem       Date:  2003-08-01       Impact factor: 4.429

5.  HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia.

Authors:  Meixiang Yang; Chunhong Ma; Shuxun Liu; Qianqian Shao; Wenjuan Gao; Bingfeng Song; Jintang Sun; Qi Xie; Yun Zhang; Alei Feng; Yanguo Liu; Weixu Hu; Xun Qu
Journal:  Immunol Cell Biol       Date:  2009-10-20       Impact factor: 5.126

6.  The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells.

Authors:  Jeffrey M Wilson; William G Ross; Oma N Agbai; Renea Frazier; Robert A Figler; Jayson Rieger; Joel Linden; Peter B Ernst
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation.

Authors:  Gabriel K Griffin; Gail Newton; Margarite L Tarrio; De-xiu Bu; Elena Maganto-Garcia; Veronica Azcutia; Pilar Alcaide; Nir Grabie; Francis W Luscinskas; Kevin J Croce; Andrew H Lichtman
Journal:  J Immunol       Date:  2012-05-07       Impact factor: 5.422

8.  Autoimmunity in CD73/Ecto-5'-nucleotidase deficient mice induces renal injury.

Authors:  Cornelia Blume; Agnieszka Felix; Nelli Shushakova; Faikah Gueler; Christine Susanne Falk; Hermann Haller; Juergen Schrader
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

9.  ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages.

Authors:  Gizem Ayna; Dmitri V Krysko; Agnieszka Kaczmarek; Goran Petrovski; Peter Vandenabeele; László Fésüs
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Unexpected link between an antibiotic, pannexin channels and apoptosis.

Authors:  Ivan K H Poon; Yu-Hsin Chiu; Allison J Armstrong; Jason M Kinchen; Ignacio J Juncadella; Douglas A Bayliss; Kodi S Ravichandran
Journal:  Nature       Date:  2014-03-12       Impact factor: 49.962

View more
  284 in total

1.  Adenosine 2a Receptor Signal Blockade of Murine Autoimmune Arthritis via Inhibition of Pathogenic Germinal Center-Follicular Helper T Cells.

Authors:  Shirdi E Schmiel; Lokesh A Kalekar; Na Zhang; Thomas W Blankespoor; Londyn J Robinson; Daniel L Mueller
Journal:  Arthritis Rheumatol       Date:  2019-03-25       Impact factor: 10.995

2.  Surfactant inhibits ATP-induced release of interleukin-1β via nicotinic acetylcholine receptors.

Authors:  Sören Backhaus; Anna Zakrzewicz; Katrin Richter; Jelena Damm; Sigrid Wilker; Gabriele Fuchs-Moll; Mira Küllmar; Andreas Hecker; Ivan Manzini; Clemens Ruppert; J Michael McIntosh; Winfried Padberg; Veronika Grau
Journal:  J Lipid Res       Date:  2017-04-12       Impact factor: 5.922

Review 3.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

4.  Purinergic signaling modulates the cerebral inflammatory response in experimentally infected fish with Streptococcus agalactiae: an attempt to improve the immune response.

Authors:  Carine F Souza; Matheus D Baldissera; Nathiele B Bottari; Karen L S Moreira; Maria Izabel U M da Rocha; Marcelo L da Veiga; Roberto C V Santos; Bernardo Baldisserotto
Journal:  Mol Cell Biochem       Date:  2017-10-31       Impact factor: 3.396

Review 5.  Pain in ankylosing spondylitis: a neuro-immune collaboration.

Authors:  Katayoon Bidad; Eric Gracey; Kasey S Hemington; Josiane C S Mapplebeck; Karen D Davis; Robert D Inman
Journal:  Nat Rev Rheumatol       Date:  2017-06-15       Impact factor: 20.543

Review 6.  Purinergic receptors and neglected tropical diseases: why ignore purinergic signaling in the search for new molecular targets?

Authors:  P A F Pacheco; L P Dantas; L G B Ferreira; Robson Xavier Faria
Journal:  J Bioenerg Biomembr       Date:  2018-06-07       Impact factor: 2.945

Review 7.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases.

Authors:  Tao Gong; Lei Liu; Wei Jiang; Rongbin Zhou
Journal:  Nat Rev Immunol       Date:  2019-09-26       Impact factor: 53.106

Review 8.  The Role of Adenosine Receptor Activation in Attenuating Cartilaginous Inflammation.

Authors:  Jonathan M Bekisz; Christopher D Lopez; Carmen Corciulo; Aranzazu Mediero; Paulo G Coelho; Lukasz Witek; Roberto L Flores; Bruce N Cronstein
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

9.  Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain.

Authors:  Yuri Kato; Miki Hiasa; Reiko Ichikawa; Nao Hasuzawa; Atsushi Kadowaki; Ken Iwatsuki; Kazuhiro Shima; Yasuo Endo; Yoshiro Kitahara; Tsuyoshi Inoue; Masatoshi Nomura; Hiroshi Omote; Yoshinori Moriyama; Takaaki Miyaji
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

10.  Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells.

Authors:  Yuliia Kaljas; Chengqian Liu; Maksym Skaldin; Chengxiang Wu; Qing Zhou; Yuanan Lu; Ivona Aksentijevich; Andrey V Zavialov
Journal:  Cell Mol Life Sci       Date:  2016-09-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.